Evidence map›Paper›PMID 38298661›Full record

ArticleHeliyon2024

Development and characterization of non-proprietary ultra high performance concrete.

Muhammad Azhar Saleem, Faizan Liaquat, Muhammad Mazhar Saleem, Mubashir Aziz, Fahid Aslam, Abdullah Mohamed

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad Azhar SaleemDepartment of Civil Engineering, University of Engineering and Technology Lahore, Lahore, Pakistan.
Faizan LiaquatDepartment of Civil Engineering, University of Engineering and Technology Lahore, Lahore, Pakistan.
Muhammad Mazhar SaleemDepartment of Civil Engineering, University of Engineering and Technology Lahore, Lahore, Pakistan.
Mubashir AzizDepartment of Civil and Environmental Engineering, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.
Fahid AslamDepartment of Civil Engineering, College of Engineering in Al-Kharj, Prince Sattam bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia.
Abdullah MohamedAbdullah Mohamed Research Centre, Future University in Egypt, New Cairo, 11835, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents the developmental process of ultra-high performance concrete (UHPC), the most advanced form of concrete. The entire process exclusively utilized locally available materials. The mixes were prepared without using any specialized mixer or treatments, such as elevated pressure, etc. The primary objective of the research was to develop low-cost non-proprietary version of UHPC by optimizing both cementitious and non-cementitious materials to attain the highest levels of workability, compressive strength, flexural strength and durability. The research utilizes a trial-and-error approach, subjecting specimens to curing in both regular and heated water. The findings validate the viability of producing self-compacting UHPC with compressive strength ranging from 120 to 160 MPa, employing local materials and manufacturing methods. Raw materials and mixing sequence had a significant influence on the fresh and hardened properties of UHPC. The inclusion of steel fibers and the application of heat treatment remarkably enhanced the compressive strength. Furthermore, cost analysis revealed that this particular UHPC is only slightly over four times more expensive than conventional concrete, in contrast to commercially available UHPC, which is approximately 10 times expensive than traditional concrete.

Indexed as

CharacterizationLow-costNon-proprietaryUHPCUltra high performance concrete

Identifiers

PMID38298661
PMCPMC10828644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.